170. Occipital horn syndrome Disease details / Clinical trials / Drug dev / DR info
Clinical trials : 2 / Drugs : 4 - (DrugBank : 3) / Drug target genes : 9 - Drug target pathways : 14
Drugs and their primary sponsors and trial info
Copper Histidine
Cyprium Therapeutics, Inc.
2009 Phase 3 NCT00811785 United States;
Droxidopa
Stephen G. Kaler, MD
2021 Phase 1/Phase 2 NCT04977388 United States;
Cyprium Therapeutics, Inc.
2009 Phase 3 NCT00811785 United States;
Droxidopa
Stephen G. Kaler, MD
2021 Phase 1/Phase 2 NCT04977388 United States;